In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...
News Medical on MSN1h
Breakthrough discovery unveils potential treatment for hepatitis BIn their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...
"We were delighted to discover not only important details about the mechanisms of HBV gene regulation, but also a promising ...
Hepatitis C treatment has undergone a remarkable transformation New antiviral medications offer shorter more effective ...
Four-year results of a phase III trial showed that budesonide oral suspension (Eohilia) for eosinophilic esophagitis was well ...
GlobalData on MSN7h
Precision reports initial outcomes from Hepatitis B trial of PBGENE-HBVThe trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.
Deep Track, a Greenwich, Ct., investment management company that holds 13.5% of Dynavax's stock, pointed its finger at ...
Albert Heijn is once again selling bags of store-brand frozen blueberries. This was confirmed by a spokesperson of the ...
The New York City Health Department is warning patrons of a Manhattan restaurant about possible exposure to the hepatitis A ...
The NHS will automatically test patients for HIV, Hepatitis B and Hepatitis C unless they opt out at 90 hospitals.
People aged 16 and over who receive blood tests in A&E at Leeds General Infirmary and St James's University Hospital are now ...
As Dynavax's second-largest investor with a 13.5% stake, Deep Track describes itself as a loyal shareholder which believes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback